Carmen Chillón

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Miguel Á. Sanz, Consuelo Rayón, Jordi Esteve et al. · PubMed · 1999 · 410 citations

Medicine, Oncology, Pharmacology +15

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia

Cristina Jiménez, Elena Sebastián, Carmen Chillón et al. · Leukemia · 2013 · 267 citations · Full text

Life Sciences, Genetics, Molecular Genetics +4

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling

Norma C. Gutiérrez, María Eugenia Sarasquete, Irena Misiewicz-Krzemińska et al. · Leukemia · 2010 · 210 citations

Life Sciences, Molecular Biology, Oncology +17

Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

Noemí Puig, María Eugenia Sarasquete, Ana Balanzategui et al. · Leukemia · 2013 · 170 citations

Medicine, Hematology, Pathology +16

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group

Miguel Á. Sanz, Pau Montesinos, Edo Vellenga et al. · Blood · 2008 · 153 citations · Full text

Medicine, Oncology, Pharmacology +15